Paradeep Phosphates Limited (NSE:PARADEEP)
India
· Delayed Price · Currency is INR | Market Cap | 139.51B |
| Revenue (ttm) | 181.80B |
| Net Income (ttm) | 9.03B |
| Shares Out | 1.04B |
| EPS (ttm) | 11.05 |
| PE Ratio | 12.16 |
| Forward PE | 13.02 |
| Dividend | 1.00 (0.74%) |
| Ex-Dividend Date | Aug 22, 2025 |
| Volume | 4,474,572 |
| Average Volume | 6,859,961 |
| Open | 136.49 |
| Previous Close | 135.91 |
| Day's Range | 133.60 - 137.80 |
| 52-Week Range | 99.70 - 234.39 |
| Beta | -0.24 |
| RSI | 65.23 |
| Earnings Date | May 15, 2026 |
About Paradeep Phosphates
Paradeep Phosphates Limited manufactures, trades, distributes, and sells urea and complex fertilizers in India. It offers di-ammonium phosphate; nitrogen, phosphorus, potassium fertilizers; muriate of potash; triple super phosphate; zypmite; phospho-gypsum; sulphuric acid; hydrofluorosilicic acid; and ammonia; as well as sulphur and zinc. It sells its products through dealers and retailers under the Navratna and Jai Kisaan brand names. The company was incorporated in 1981 and is based in Bengaluru, India. Paradeep Phosphates Limited is a subsid... [Read more]
Financial Performance
In fiscal year 2025, Paradeep Phosphates's revenue was 138.20 billion, an increase of 19.40% compared to the previous year's 115.75 billion. Earnings were 5.52 billion, an increase of 452.29%.
Financial StatementsNews
Paradeep Phosphates Transcript: Q3 25/26
Production and sales saw double-digit growth, with EBITDA up 45% and PAT up 71% year-over-year. Backward integration and energy efficiency projects are set to boost margins, while debt and liquidity remain well managed despite raw material price volatility.
Paradeep Phosphates Transcript: Q2 25/26
Q2 and H1 FY26 saw robust revenue and profit growth, driven by higher production, sales, and improved product mix. Major capacity expansion and full backward integration are underway, with new investments to be funded by a mix of debt and equity.
Paradeep Phosphates Transcript: Q1 25/26
Revenue grew 58% YoY with EBITDA nearly doubling, driven by higher volumes, improved product mix, and strong operational execution. Inventory and trade receivables improved, while capacity expansions and the MCFL merger are set to enhance scale and integration.
Paradeep Phosphates Transcript: Q4 24/25
FY 2025 saw record profitability and sales, with revenue up 19% and PAT up 452% year-over-year. Operational efficiency, backward integration, and strong rural demand drove growth, while ongoing CapEx and the MCFL merger are set to further boost capacity and margins.
Paradeep Phosphates Transcript: Q3 24/25
Q3 FY 2025 delivered strong revenue and sales growth, driven by robust NPK and nano-fertilizer performance, while DAP margins contracted due to higher input costs. Backward integration and capacity expansions are on track, with full benefits expected in FY 2026.
Paradeep Phosphates Transcript: Q2 24/25
Q2 FY25 saw strong volume and earnings growth, driven by favorable agri conditions, product mix shift, and strategic integration. EBITDA and PAT surged, with robust cash flow and reduced leverage. CapEx for phosphoric acid expansion is set to further boost margins.
Paradeep Phosphates Transcript: Q1 24/25
Q1 FY25 saw lower production and sales volumes due to a brief shutdown, but profitability improved year-over-year. New product launches and robust Q2 demand position the company to exceed last year's volumes, though rising raw material costs may require price corrections if government support is not provided.